Corporate DoubleRainbow Biosciences Announces Strategic AI Collaboration with Galixir Press Release 7 Nov 2022
Corporate Double Rainbow Announces World’s First Commercial-Scale Biosynthetic Gastrodin, a Natural Analgesic with a Range of Therapeutic Applications Press Release 28 Nov 2022
Corporate DoubleRainbow Biosciences and Kelai Pharmaceuticals to collaborate on novel natural compound therapeutics Press Release 22 Aug 2022
Corporate Double Rainbow announces $10 million investment from Betta Pharmaceuticals Press Release 10 Aug 2021